Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1679626170
Physician

Zacoalco Medical Group INC

Zacoalco Medical Group INC was paid $2.74M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.

33Billing provider infoZACOALCO MEDICAL GROUP INC
BAKERSFIELD, CA 93306
33aNPI1679626170assigned 01/19/2007
28Total paid$2.74M
24GClaims116,220
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Obstetrics & Gynecology Physician providers in California

Rank by total paid#50 of 791
Median peer was paid$67K
This provider vs. median41×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201814,692$343K
201923,501$359K
202021,475$336K
202111,575$347K
202212,347$379K
202314,936$329K
2024incomplete17,694$648K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 54% 35,919 25,499 $1.49M
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 5.5% 1,318 1,305 $152K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 5.5% 556 554 $151K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4.5% 2,421 2,211 $123K
99406 4.5% 11,105 8,337 $122K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 3.8% 1,447 1,436 $105K
93000 2.7% 2,189 2,163 $73K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 2.6% 711 681 $71K
93880 2.1% 322 320 $59K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2.1% 998 993 $57K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.4% 1,672 1,570 $39K
92551 1.4% 3,003 2,956 $39K
73 more codes
G8510 Screening for depression is documented as negative, a follow-up plan is not required 1.0% 1,903 $28K
G9920 Screening performed and negative <1% 636 $22K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,122 $18K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 651 $18K
99173 <1% 3,968 $15K
71046 Radiologic examination, chest; 2 views <1% 447 $13K
81002 <1% 6,762 $12K
90686 <1% 759 $12K
86328 <1% 265 $12K
99203 Doctor's office visit, new patient (routine) <1% 204 $12K
90791 Psychiatric diagnostic evaluation <1% 63 $10K
85018 <1% 4,959 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,858 $8K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 211 $7K
99214 Doctor's office visit, returning patient (more involved) <1% 192 $7K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 182 $7K
92552 <1% 482 $6K
82962 <1% 3,152 $6K
96156 <1% 322 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 943 $5K
G9919 Screening performed and positive and provision of recommendations <1% 124 $4K
90651 <1% 352 $4K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 72 $3K
90734 <1% 298 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 577 $3K
90714 <1% 65 $2K
99407 <1% 101 $2K
99385 <1% 24 $2K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 12 $2K
90674 <1% 42 $1K
G8431 Screening for depression is documented as being positive and a follow-up plan is documented <1% 24 $874.44
90756 <1% 30 $708.30
99000 <1% 551 $669.38
90715 <1% 54 $579.60
97802 <1% 331 $460.00
96151 <1% 152 $404.08
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 27 $398.13
90621 <1% 28 $339.20
90700 <1% 29 $320.80
99401 <1% 419 $255.17
90670 <1% 15 $160.20
90648 <1% 14 $158.80
83655 <1% 14 $148.82
90713 <1% 12 $148.00
86580 <1% 31 $97.10
81025 <1% 26 $69.41
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 331 $26.71
82947 <1% 14 $21.01
3079F 0% 908 $0.00
4050F 0% 2,930 $0.00
3074F 0% 1,427 $0.00
1125F 0% 1,085 $0.00
3008F 0% 3,118 $0.00
G8754 Most recent diastolic blood pressure < 90 mmhg 0% 1,138 $0.00
3080F 0% 298 $0.00
3014F 0% 45 $0.00
3075F 0% 513 $0.00
3044F 0% 285 $0.00
3048F 0% 171 $0.00
3052F 0% 12 $0.00
3049F 0% 71 $0.00
88150 0% 29 $0.00
3017F 0% 37 $0.00
3077F 0% 1,997 $0.00
1159F 0% 1,434 $0.00
3078F 0% 2,520 $0.00
0521F 0% 1,096 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 0% 370 $0.00
1160F 0% 1,421 $0.00
96160 0% 722 $0.00
3015F 0% 27 $0.00
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 0% 39 $0.00
3050F 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDE LA ROSA, SAUL (PRESIDENT)
Parent organizationZACOALCO MEDICAL GROUP INC
Same official

Other billing entities under DE LA ROSA, SAUL

Full network →
ProviderLocationPaid
Zacoalco Urgent Care Center INCLos Angeles, CA$93K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.